Tofacitinib Impurity 34 | CAS 1111638-10-8 - Request Quote
Tofacitinib Impurity 34
| SZ CAT No: | SZ-T010088 |
| CAS No | 1111638-10-8 |
| Mol.F. | C5H3ClN4 |
| Mol.Wt. | 154.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Tofacitinib Impurity 34 is chemically 6-chloro-1H-imidazo[4,5-b]pyrazine. Tofacitinib Impurity 34 is supplied with detailed characterization data compliant with regulatory guideline. Tofacitinib Impurity 34 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Tofacitinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1111638-10-8
Purchase 1111638-10-8
Order 1111638-10-8
Enquire 1111638-10-8
price of 1111638-10-8
1111638-10-8 Supplier
1111638-10-8 Manufacturer
1111638-10-8 Exporter
buy high quality Tofacitinib Impurity 34
Purchase Tofacitinib Impurity 34
Tofacitinib Impurity 34 suppliers
Tofacitinib Impurity 34 manufacturers
Tofacitinib Impurity 34 price
Order Tofacitinib Impurity 34
Enquire Tofacitinib Impurity 34
Tofacitinib Impurity 34 cost
Tofacitinib Impurity 34 Supplier
Tofacitinib Impurity 34 Distributor
Tofacitinib Impurity 34 for Method Validation
Tofacitinib Reference Standard
Tofacitinib Impurity 34 for ANDA Filing
Tofacitinib Impurity 34 for Forced Degradation Studies
Tofacitinib Impurity 34 Identification Standards
Tofacitinib Impurity 34 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.